药物诱导的儿童肺部疾病
Andrew H Schapiro1,2, Kristen L Ruff3,4, R Paul Guillerman3,4
1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. andrew.schapiro@cchmc.org.
Pediatric radiology
|November 25, 2025
概括
儿科药物诱导的肺病虽然很少见,但会带来很大的风险. 识别特定的CT模式有助于放射科医生在早期诊断和管理这种严重疾病.
科学领域:
- 儿科肺病学 儿科肺病学
- 放射学 放射学是一门学科.
- 临床药理学 临床药理学
背景情况:
- 在儿童中,药物诱导的肺病 (MILD) 是不常见但严重的.
- 它可以显著影响患者的发病率,死亡率和治疗计划.
- 某些药物类别经常与MILD有关.
研究的目的:
- 在儿科患者中审查与MILD相关的药物类别.
- 概述MILD的临床诊断和管理策略.
- 通过CT发现突出放射科医生在识别MILD方面的作用.
主要方法:
- 在儿童群体中MILD的文献综述.
- 对涉及MILD的常见药物类别的分析.
- MILD与特征性计算机断层扫描 (CT) 模式的相关性.
主要成果:
- MILD与特定的药物类别有关.
- 在儿科MILD中观察到明显的CT模式.
- 放射科医生在早期检测中发挥着至关重要的作用.
结论:
- 放射科医生对MILD的早期识别至关重要.
- 了解CT的表现有助于及时诊断.
- 多学科的方法可以改善儿童的MILD管理.
相关概念视频
Inhaled Medications
702
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
702
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Pulmonary Cycle: Exhalation
3.0K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.0K
Drug Dosing: Infants and Children
235
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235


